
The 12-week study involved 251 participants using basal insulin therapy. The intervention group used the My Dose Coach app to adjust insulin doses, while the control group followed a written titration chart. Results showed the app users had a significant improvement in glycemic control, with a 0.31% reduction in HbA1c levels compared to the control group. No safety concerns were associated with the app use.
Like
Save
Share